Status:
COMPLETED
Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
Lead Sponsor:
Clinique Ovo
Conditions:
Fertility Disorders
Eligibility:
FEMALE
Up to 40 years
Brief Summary
In frozen embryo transfer substituted cycles, patients are treated with progesterone and estrogen in an attempt to mimic the natural cycle and a transfer is planned whenever the endometrium is ready. ...
Eligibility Criteria
Inclusion
- Age \< 40 years old
- Women having undergone either a frozen embryo transfer in natural cycle or substituted cycle
- IVF and FET cycles done at Clinique OVO
Exclusion
- egg or embryo recipient
- History of recurrent miscarriages, defined as ≥ 3 consecutive losses
- Patients that needed Viagra, Plasma-Rich Platelet (PRP) or other modalities to improve their endometrial thickness
- Uterine abnormalities
- Abnormal hormonal profiles
- FET Stimulated cycles
- History of recurrent implantation failure defined as failed ≥ 2 euploid embryos transfer or ≥ 3 blastocysts
Key Trial Info
Start Date :
September 19 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 18 2024
Estimated Enrollment :
1207 Patients enrolled
Trial Details
Trial ID
NCT06053827
Start Date
September 19 2023
End Date
July 18 2024
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Ovo
Montreal, Quebec, Canada, H4P 2S4